Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?

Journal of the American Geriatrics Society

Volumn 50, Issue 7, 2002, Pages 1198-1204

  Lapane, Kate L ^a,d   Hume, Anne L ^b   Barbour, Marilyn M ^b   Lipsitz, Lewis A ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

ACE inhibitors; Aspirin; Heart failure; Ischemic heart disease; Nursing homes

Indexed keywords

ACETYLSALICYLIC ACID; BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; QUINAPRIL; RAMIPRIL;

AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PHYSICAL ACTIVITY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; DRUG INTERACTIONS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036062469     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50305.x     Document Type: Article

References (32)

1. The management of chronic heart failure
2. 15 Years of heart-failure trials: What have we learned?
3. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation & Management of Heart Failure)
4. The treatment of heart failure
5. North of England evidence based development project: Guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure
6. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association
7. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
8. Interaction between enalapril and aspirin on mortality after myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
9. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease
10. Time to focus on the more typical heart-failure patients
11. Validity of diagnostic and drug data in standardized nursing home assessments: Potential for geriatric pharmacoepidemiology
12. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status
13. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action
14. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors
15. Management of heart failure among very old individuals living in long-term care: Has the voice of trials spread?
16. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
17. Antithrombotic agents in coronary artery disease
18. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Trial
19. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
20. Final report on the aspirin component of the ongoing physician's health study
21. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results
22. Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure
23. Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release?
24. Does aspirin treatment influence vascular resistance and fluid filtration in patients with congestive heart failure?
25. Consultation between cardiologists and generalists in the management of acute myocardial infarction: Implications for quality of care
26. Evaluating use of angiotensin-converting enzyme inhibitors for elderly nursing home residents with chronic heart failure
27. Survival of elderly men with congestive heart failure
28. Preserved left ventricular systolic function versus systolic dysfunction in congestive heart failure: A comparison of clinical characteristics, hospital readmission rates, and survival
29. CHF with preserved systolic function: Mortality, readmission rate, and ACE inhibitor effect in a statewide sample of community hospitals